awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39296548-178A2197-D318-4338-95CE-9914DFF5219E
Q39296548-178A2197-D318-4338-95CE-9914DFF5219E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39296548-178A2197-D318-4338-95CE-9914DFF5219E
Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint pha
P2860
Q39296548-178A2197-D318-4338-95CE-9914DFF5219E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39296548-178A2197-D318-4338-95CE-9914DFF5219E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a29f4e9b0ebcab834cdd1550e1545245e2a7674
P2860
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.